ALT vs IBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 18, 2026

ALT

40.0
AI Score
VS
IBIO Wins

IBIO

44.4
AI Score

Investment Advisor Scores

ALT

40score
Recommendation
HOLD

IBIO

44score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ALT IBIO Winner
Revenue 42,000 100,000 IBIO
Net Income -63.05M -8.99M IBIO
Net Margin -150126.2% -8993.0% IBIO
Operating Income -64.65M -15.40M IBIO
ROE -30.8% -15.9% IBIO
ROA -28.0% -14.0% IBIO
Total Assets 225.28M 64.39M ALT
Cash 127.47M 28.67M ALT
Current Ratio 13.40 9.04 ALT
Free Cash Flow -45.37M -11.45M IBIO

Relative Price Performance (Last 90 Days)

ALT 1M: -16.6% · 3M: -11.2% IBIO 1M: -14.1% · 3M: -30.6%

Current Technical Phase

ALT

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 32

RSI (14): 31.6 · Price: $2.74

IBIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.5%), weak momentum, RSI 35

RSI (14): 34.8 · Price: $1.13

Fundamentals Snapshot

Metric ALT IBIO
Market Cap — —
Forward P/E -4.1 -3.6
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 4.2% -1.0%
Gross Margin -2151.4% 1.0%
Operating Margin -3184.9% -301.4%
EPS -0.76 -0.30
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, IBIO is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.